Great discussion [Design Issues]

posted by Ohlbe – France, 2020-01-02 17:57 (1546 d 19:07 ago) – Posting: # 21053
Views: 7,163

Dear ElMaestro,

❝ Can you guys think of any other biomarker/indicator unrelated to blood loss or the regenerative process?


Needle prick marks in the forearm veins, if the subject is so greedy (or hungry :-() that he does not even wait for them to heal ? Well, actually it would be relevant, if I am to believe Zeba Ziddiqui's paper which you mentioned earlier (with subjects participating in 3 or 4 trials in the same month). I never saw a protocol with a non-inclusion criterion "Subject with needle marks in the forearm". So I never saw a tick box anywhere in the screening documentation with this criterion.

I'm not aware of any other indicator, unfortunately.

By the way, I really don't see how a subject could participate in 3 or 4 trials in the same month without the CRO(s) being aware of it. I'm really not sure whether some of the CROs are really willing to know whether the subjects cross-participate.

[image] © Roberto Mangosi

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
22,957 posts in 4,819 threads, 1,639 registered users;
72 visitors (0 registered, 72 guests [including 5 identified bots]).
Forum time: 13:05 CET (Europe/Vienna)

Nothing shows a lack of mathematical education more
than an overly precise calculation.    Carl Friedrich Gauß

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5